Nick Grooss gooide het roer radicaal om. Hij stopte met zijn professionele polo carrière in Argentinië en nam een macademia noten kwekerij over in Zuid Afrika. 

Hiermee was Welgelegen Macademia (WelMac) geboren. Een duurzaam macadamia productie- en handelsbedrijf dat veel positieve impact heeft op de lokale mensen en het gebied rondom de kwekerij in Limpopo in Zuid Afrika.

In deze podcast is Nick te gast samen met Investment Manager Barry Brouns van het Dutch Good Growth Fund (DGGF). Je hoort hoe Nick en zijn internationale team uitdagingen overwinnen met behulp van het DGGF en hoe ze samen werken aan een betere toekomst. Presentatie: Folkert Tempelman. 

We maakten deze podcast samen met de Rijksdienst voor Ondernemend Nederland. Wil je meer weten over de mogelijkheden van de RVO en het Dutch Good Growth Fund - waar Nic met WelMac tot twee keer toe veel aan heeft gehad in Zuid Afrika - check dan hun site: rvo.nl/dggf. 

www.welmac.nl 
www.grenzeloosondernemen.com 
rvo.nl/subsidies-regelingen/dutch-good-growth-fund-dggf
rvo.nl/subsidie-en-financieringswijzer/dutch-trade-and-investment-fund-dtif
rvo.nl/onderwerpen/internationaal-ondernemen

WelMac (GO#039)

In this (Dutch) interview, Erika Werner, PhD, explains advances in cancer research.  

This interview was conducted  during the 2013 annual meeting of the American Society of Clinical Oncology (ASCO), which was being held in Chicago (May 31 -  June 4, 2013).  This interview is based on Werner's presentation "Phosphatidylinositide 3-Kinase Pathway in Gynecological Cancers", and was broadcast on Paradise FM (Curacao, NA) on Jun 3, 2013.

For more information, go to Onco'Zine - The International Oncology Network (http://www.oncozine.com)

Peter Hofland's tracks - Erika Werner, PhD Interview (made with Spreaker)

A weekly program about cancer and cancer treatment.

Treatment SOS 02-06-2014

Treatment SOS 01-23-2014

Born and raised in Curaçao NA, an island in the southern Caribbean Sea, Bob Pinedo, MD, PhD, now professor emeritus and a consultant to the Board of the Free University Medical Center in Amsterdam, The Netherlands, remains a real powerhouse in the World of Oncology.

He has spent more than 40 years researching cancer biology, drug treatment and resistance, and it can be said that his accomplishments have helped to better understand cancer treatment.  

Here in the United States he has worked with a number of pioneers in oncology – including Dr. Bruce A. Chabner, at the National Cancer Institute (NCI) - where he conducted pharmacology studies to understand the effect of certain drugs on bone marrow stem cells.

He introduced the medical community to a process of multidisciplinary treatment across hematology, surgical and radiation oncology…

...and helped develop new clinical strategies.

The work Dr. Pinedo did to accomplish his goal was recognized by his peers. As a result, in 2014, during the 50th aniversary of the American Society of Clinical Oncology (ASCO), he received the David A. Karnofsky Memorial Award and Lecture.

First presented in 1970, the award recognizes oncologists who have made outstanding contributions to cancer research, diagnosis, or treatment.

Dr. Bob Pinedo: A Real Powerhouse in the World of Oncology

In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben & Catherine Ivy Foundation. 

The Ben & Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma (GBM) - research in the world. To date, the Ivy Foundation has funded clinical trials and basic science in North America, Europe, and Asia.  

Glioblastoma, also known as glioblastoma multiforme, is an aggressive type of cancer that can occur in the brain or spinal cord. Glioblastoma forms from cells called astrocytes, that support nerve cells. The disease can occur at any age, but tends to occur more often in older adults. 

Glioblastoma can cause worsening headaches, nausea, vomiting and seizures. It can be very difficult to treat and a cure is often not possible. 

Catherine Ivy, is a tireless advocate for glioblastoma patients everywhere.  

Since 2005, the Ivy foundation has committed more than US $ 92 million to brain tumor research.  The expectation is that this investment will, in time, lead to an eventual cure. The Ivy Foundation is dedicated to this effort because funding leads to answers, and answers lead to hope.

Ivy Foundation-supported research is always patient-focused and highly translational.  The organizational philosophy is to embrace risk, advocate collaboration, and fiercely support the brain tumor patient community.  

This forward-leaning strategy reflects the ideals of both Ms. Ivy and her late husband, Ben, who died from a glioblastoma in 2005.  

In this interview with The Onco'Zine Brief, Catherine Ivy tells the story of her husband, Ben Ivy, who was diagnosed with glioblastoma in August 2005. In addition to his devastating diagnosis, Ben’s suffering made a difficult situation overwhelmingly painful –  Ben Ivy passed away four months after being diagnosed, in November 2005. 

Ben and Catherine Ivy felt it was important to give back to their community and they’ve always actively supported education and healthcare. Following Ben’s death, the Ben and Catherine Ivy foundation refocused its mission to find a cure for brain cancer.  

Catharine Ivy explained that her husband’s suffering and the awareness of the lack of options to fight brain cancer motivated her to find better diagnostics and to develop new therapies to help patients.

And that’s what she did.

The mission of the Ben and Catherine Ivy Foundation is to fund brain cancer research in order to develop diagnostics and treatments that lead to long-term survival and a high quality of life for patients with this disease. 

More information about the Ben and Catherine Ivy Foundation
For more information about the Ben and Catherine Ivy Foundation, visit the website of the organization at:  www.ivyfoundation.org  

About Onco'Zine
The Onco’Zine Brief is developed in collaboration with the online journal, Onco’Zine at oncozine.com - where you can find additional information and the latest news about cancer, cancer diagnosis and treatment, and cancer prevention.

How to support The Onco'Zine Brief
For more information about supporting The Onco’Zine Brief, check our online journal Onco’Zine at Onco’Zine.com or visit Patreaon at https://www.patreon.com/theoncozinebrief

Newsletter
If you’re living in the United States and want to receive our Newsletter, text the word CANCER to 66866 - and we’ll make sure that you’ll receive our newsletter which includes an overview of the latest news in oncology and hematology.

Read more
- Hofland P. First-in-human Study to Determine Effectiveness of Novel, Non-invasive Therapy for Brain Cancer. Onco'Zine. November 21, 2019. Online: https://www.oncozine.com/first-in-human-study-to-determine-effectiveness-of-novel-non-invasive-therapy-for-brain-cancer/
- Hofland P. New Breast Cancer Drug has the Potential to be a Novel Therapy for Glioblastoma. Onco'Zine, July 25, 2019. Online: https://www.oncozine.com/new-breast-cancer-drug-has-the-potential-to-be-a-novel-therapy-for-glioblastoma/
- Nader Sanai, MD, FAANS, FACS. As New Drugs Lag, Accelerated Clinical Trials Lead Charge in Brain Cancer Fight? Onco'Zine. April 12, 2019. Online: https://www.oncozine.com/as-new-drugs-lag-accelerated-clinical-trials-lead-charge-in-brain-cancer-fight%ef%bb%bf/

Catherine Ivy: A Tireless Advocate for Brain Cancer Patients

Peter Hofland, Ph.D. is the host of The Onco'Zine Brief, a radio show/podcast especially designed for the community of medical and healthcare professionals in oncology and hematology as well as cancer patients, their families, and caregivers. 

In the show, Hofland talks about the latest researcher, developments, and news in cancer and cancer treatment. They also interview physicians, world-renowned researchers, Key Opinion Leaders/Experts, and Key Stakeholders who share the common objective of preventing cancer, fostering a favorable environment for scientific research, and advocating for equal access to high-quality cancer treatment, and educate cancer patients and their friends and family.

Dr. Bob Pinedo: A Real Powerhouse in the World of Oncology

The Onco'Zine Brief with Peter Hofland

Related tracks